Prior Intimation


General Information

NSE Symbol* NEPHROCARE
Name of the Company* NEPHRO CARE INDIA LIMITED
ISIN* INE0SUN01013
Type of Meeting 1)   Board Meeting
Details of Committee Meeting or Other Type of Meeting
Type of Intimation* New
Reason for Re-schedule (postpone or prepone) / Cancellation
Proposed Meeting Date 2025-07-10
Original Meeting Date
Whether trading window is closed* No
Trading Window Closure- Start date
Details of Trading Window Closure End date
Short Notice
Date of Report* 2025-07-01



Agenda Details

Agenda* 1)   Other business
Whether results are audited or unaudited
Nature of report standalone or consolidated
Period end Type
Period up to (Month)
Period up to (Year)
Mode of raising Funds
Type of Dividend
Remarks (website dissemination) 1. To elect the Chairman of the Meeting. 2. To grant leave of absence, if any. 3. To Confirm and sign the minutes of the last Board Meeting held on 28th day of May 2025. 4. To Approve the Directors Report along with its annexures of the Company for the financial year ended 31st March 2025. 5. To Appoint M/s Saptasikha & Co. (Membership No. F10783, CP No.:15239, Peer Review No. 3829/2023), a practicing Company Secretary, as the Secretarial Auditor of the Company, for a term of 5 (five) consecutive years commencing from April 1, 2025 and ending on March 31, 2030. 6. To Appoint M/s M. Dutta & Associates (Firm Registration No. 330317E) Chartered Accountants, as the Internal Auditor of the Company for the financial year 2025-26. 7. To Fix the date of 11th Annual General Meeting and approve the draft notice thereof. 8. To Appoint M/s Saptasikha & Co. (Membership No. F10783, CP No. :15239, Peer Review No. 3829/2023), a practicing Company Secretary, as Scrutinizer for the ensuing Annual General Meeting of the Company. 9. Approval for incorporation of Special Purpose Vehicle (“SPV”) for Bandra by way of subsidiary company or by way of Limited Liability Partnership (“LLP”). 10. Approval for appointment of a New Stockiest for the Company. 11. Any other matter as may be discuss by the Chairman.